Skip to main content
Watch Insiders
PTCT filings

Corporate insider profile

Mark Elliott Boulding Filing Activity

Latest reported as EXEC. VP AND CLO of PTC THERAPEUTICS, INC. (PTCT).

Purchase filings
0
Reported companies
1
Net open-market value
-$1,305,395.84
Latest transaction
Jun 17, 2026

Affiliated corporations

Reported company relationships

PTCTLatest reported

PTC THERAPEUTICS, INC.

EXEC. VP AND CLO

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 17, 2026PTC THERAPEUTICS, INC. (PTCT)EXEC. VP AND CLOSale10,462$78.65$822,868
May 15, 2026PTC THERAPEUTICS, INC. (PTCT)EXEC. VP AND CLOSale2,812$72.18$202,958
May 8, 2026PTC THERAPEUTICS, INC. (PTCT)EXEC. VP AND CLOSale3,540$78.97$279,570